Intravenous Immunoglobulin (IVIg) for Parvovirus B19(PVB19) Mediated Cardiomyopathy
NCT00892112
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Myocardial Diseases
Parvovirus B19, Human
Interventions
DRUG:
Intravenous Immunoglobulins
DRUG:
plasma volume expander
Sponsor
Prothya Biosolutions